Minocycline for the Treatment of Early-Phase Schizophrenia

NCT00733057 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Negative and Cognitive Symptoms in Schizophrenia

Interventions

DRUG: Minocycline
DRUG: Placebo (200 mg/day)

Sponsor

Shalvata Mental Health Center

Collaborators

[object Object]